立即開始
Iovance Biotherapeutics, Inc.
看多
已更新

FOR JERRY #1 OF 3, IOVA

139
This is 12-month outlook for IOVA from several different angles (meaning sized bars, heavy emphasis on 1-day and 2-day). Temporary weakness in volume structure has been considered and expected to resolve by January 2021. Future looks bright.
註釋
Here is a zoom in for temporary weakness expected this late Nov 2020 to Jan 2021 window:

快照
Binary_Forecasting_Service
Beyond Technical AnalysisbiotechIOVAmqpPRSTrend AnalysisWave Analysis

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
Beyond Technical AnalysisbiotechIOVAmqpPRSTrend AnalysisWave Analysis
Binary_Forecasting_Service

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。